Skip to main content
. Author manuscript; available in PMC: 2018 Sep 23.
Published in final edited form as: ChemMedChem. 2016 Oct 5;11(21):2410–2421. doi: 10.1002/cmdc.201600417

Table 6.

Detailed information on the cell lines used.[a]

Cell line Histology Characteristics Growth medium Source
A431 Epidermoid carcinoma EGFR wild-type overexpression, erlotinib-sensitive RPMI-1640 ATCC
Caki-1 Renal cell carcinoma McCoy’s ATCC
Caki-2 Renal cell carcinoma McCoy’s ATCC
Calu3 NSCLC EGFR-dependent, erlotinib-sensitive MNP ATCC
HCC827 NSCLC Erlotinib-sensitive due to EGFR mutation (delE746–A750) RPMI-1640 ATCC
MCF-7 Mammary tumor, adenocarcinoma DMEM ATCC
PC-9 NSCLC Erlotinib-sensitive due to EGFR mutation (delE746–A750) RPMI-1640 CEMM–Kilian Huber
RU-MH Renal cell carcinoma RPMI-1640 Established at the ICR
HCT116 Colorectal carcinoma EGFR wild-type McCoy’s ATCC
SW480 Colorectal carcinoma EGFR wild-type MEME ATCC
H1703 Squamous cell lung carcinoma RPMI-1640 ATCC
H520 Squamous cell lung carcinoma RPMI-1640 ATCC
[a]

Abbreviations: ATCC, American Type Culture Collection; DMEM, Dulbecco’s modified Eagle’s medium; ICR, Institute of Cancer Research Vienna; MNP, minimal essential medium with non-essential amino acids and pyruvate.